Report cover image

Global Continuous Subcutaneous Insulin Infusion Market Size Study by Product, Patient Type, End-Use, and Regional Forecasts 2022-2032

Publisher Bizwit Research & Consulting
Published Jan 16, 2025
Length 285 Pages
SKU # BIZW19503178

Description

Global Continuous Subcutaneous Insulin Infusion Market Size Study by Product, Patient Type, End-Use, and Regional Forecasts 2022-2032


The Global Continuous Subcutaneous Insulin Infusion Market, valued at approximately USD 0.69 billion in 2023, is poised to grow exponentially, reaching an estimated USD 1.34 billion by 2032, with a compelling CAGR of 9.00% over the forecast period 2024-2032. This growth is primarily attributed to the increasing prevalence of diabetes worldwide, combined with the rising demand for advanced insulin delivery systems that improve glycemic control and enhance patient compliance. The transition toward minimally invasive technologies has underscored the importance of continuous subcutaneous insulin infusion (CSII) systems, which offer precision and adaptability in diabetes management.

CSII systems, encompassing patch pumps and tethered pumps, are revolutionizing the landscape of diabetes care by delivering basal and bolus insulin doses in a controlled manner. Their ability to minimize the challenges associated with traditional insulin therapy methods has significantly enhanced their adoption. Furthermore, technological advancements, such as integration with continuous glucose monitoring (CGM) systems and smartphone connectivity, have positioned these devices as indispensable tools for personalized diabetes management. However, challenges such as high costs and limited access in emerging economies remain pressing concerns, which stakeholders are addressing through strategic pricing models and educational initiatives.

The market's growth trajectory is further bolstered by favorable healthcare policies and increased investments in research and development activities. The rising prevalence of diabetes Type 1, particularly in pediatric and young adult populations, has fueled the demand for user-friendly and compact insulin infusion solutions. Additionally, expanding awareness campaigns emphasizing early diagnosis and effective diabetes management are creating robust growth opportunities across various regions.

Regionally, North America dominates the Continuous Subcutaneous Insulin Infusion Market, underpinned by a strong healthcare infrastructure, high adoption rates of innovative technologies, and a significant patient pool. Europe follows suit, driven by government initiatives promoting diabetes management and the presence of leading market players. Meanwhile, the Asia Pacific region is expected to witness the fastest growth during the forecast period, attributed to the rising incidence of diabetes, increasing healthcare spending, and growing awareness regarding advanced insulin delivery systems. Latin America and the Middle East & Africa also present promising potential, supported by improving healthcare facilities and heightened focus on diabetes care.

Major market players included in this report are:
• Medtronic plc
• Tandem Diabetes Care, Inc.
• Insulet Corporation
• Roche Diabetes Care
• Ypsomed Holding AG
• Sooil Development Co., Ltd.
• Cellnovo Group SA
• Eli Lilly and Company
• Novo Nordisk A/S
• Animas Corporation (Johnson & Johnson)
• Beta Bionics, Inc.
• Valeritas Holdings, Inc.
• Debiotech SA
• Senseonics Holdings, Inc.
• Sanofi

The detailed segments and sub-segment of the market are explained below:

By Product:
• Patch Pumps
• Tethered Pumps

By Patient Type:
• Diabetes Type 1
• Diabetes Type 2

By End-Use:
• Hospitals
• Clinics
• Homecare Settings

By Region:

North America:
• U.S.
• Canada

Europe:
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific:
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America:
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa:
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Years considered for the study are as follows:
• Historical Year: 2022
• Base Year: 2023
• Forecast Period: 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of geographical landscape with country-level insights across major regions.
• Competitive landscape featuring information on major players and their strategies.
• Analysis of key business strategies and recommendations for future market approaches.
• Comprehensive analysis of the competitive structure of the market.
• Demand-side and supply-side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Table of Contents

285 Pages
Chapter 1. Global Continuous Subcutaneous Insulin Infusion Market Executive Summary
1.1. Global Continuous Subcutaneous Insulin Infusion Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Patient Type
1.3.3. By End-Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Continuous Subcutaneous Insulin Infusion Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Continuous Subcutaneous Insulin Infusion Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Prevalence of Diabetes Worldwide
3.1.2. Rising Demand for Advanced Insulin Delivery Systems
3.1.3. Technological Advancements in Insulin Infusion Devices
3.2. Market Challenges
3.2.1. High Costs of Continuous Subcutaneous Insulin Infusion Systems
3.2.2. Limited Access in Emerging Economies
3.3. Market Opportunities
3.3.1. Expansion into Emerging Markets
3.3.2. Innovations in Device Integration and Connectivity
3.3.3. Strategic Collaborations and Partnerships
Chapter 4. Global Continuous Subcutaneous Insulin Infusion Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Continuous Subcutaneous Insulin Infusion Market Size & Forecasts by Product 2022-2032
5.1. Segment Dashboard
5.2. Global Continuous Subcutaneous Insulin Infusion Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
5.2.1. Patch Pumps
5.2.2. Tethered Pumps
Chapter 6. Global Continuous Subcutaneous Insulin Infusion Market Size & Forecasts by Patient Type 2022-2032
6.1. Segment Dashboard
6.2. Global Continuous Subcutaneous Insulin Infusion Market: Patient Type Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
6.2.1. Diabetes Type 1
6.2.2. Diabetes Type 2
Chapter 7. Global Continuous Subcutaneous Insulin Infusion Market Size & Forecasts by End-Use 2022-2032
7.1. End-Use
7.1.1. Hospitals
7.1.2. Clinics
7.1.3. Homecare Settings
Chapter 8. Global Continuous Subcutaneous Insulin Infusion Market Size & Forecasts by Region 2022-2032
8.1. North America Continuous Subcutaneous Insulin Infusion Market
8.1.1. U.S. Continuous Subcutaneous Insulin Infusion Market
8.1.1.1. End Use Breakdown Size & Forecasts, 2022-2032
8.1.1.2. Product Breakdown Size & Forecasts, 2022-2032
8.1.2. Canada Continuous Subcutaneous Insulin Infusion Market
8.2. Europe Continuous Subcutaneous Insulin Infusion Market
8.2.1. UK Continuous Subcutaneous Insulin Infusion Market
8.2.2. Germany Continuous Subcutaneous Insulin Infusion Market
8.2.3. France Continuous Subcutaneous Insulin Infusion Market
8.2.4. Spain Continuous Subcutaneous Insulin Infusion Market
8.2.5. Italy Continuous Subcutaneous Insulin Infusion Market
8.2.6. Rest of Europe Continuous Subcutaneous Insulin Infusion Market
8.3. Asia Pacific Continuous Subcutaneous Insulin Infusion Market
8.3.1. China Continuous Subcutaneous Insulin Infusion Market
8.3.2. India Continuous Subcutaneous Insulin Infusion Market
8.3.3. Japan Continuous Subcutaneous Insulin Infusion Market
8.3.4. Australia Continuous Subcutaneous Insulin Infusion Market
8.3.5. South Korea Continuous Subcutaneous Insulin Infusion Market
8.3.6. Rest of Asia Pacific Continuous Subcutaneous Insulin Infusion Market
8.4. Latin America Continuous Subcutaneous Insulin Infusion Market
8.4.1. Brazil Continuous Subcutaneous Insulin Infusion Market
8.4.2. Mexico Continuous Subcutaneous Insulin Infusion Market
8.4.3. Rest of Latin America Continuous Subcutaneous Insulin Infusion Market
8.5. Middle East & Africa Continuous Subcutaneous Insulin Infusion Market
8.5.1. Saudi Arabia Continuous Subcutaneous Insulin Infusion Market
8.5.2. South Africa Continuous Subcutaneous Insulin Infusion Market
8.5.3. Rest of Middle East & Africa Continuous Subcutaneous Insulin Infusion Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Medtronic plc
9.1.2. Tandem Diabetes Care, Inc.
9.1.3. Insulet Corporation
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Medtronic plc
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Tandem Diabetes Care, Inc.
9.3.3. Insulet Corporation
9.3.4. Roche Diabetes Care
9.3.5. Ypsomed Holding AG
9.3.6. Sooil Development Co., Ltd.
9.3.7. Cellnovo Group SA
9.3.8. Eli Lilly and Company
9.3.9. Novo Nordisk A/S
9.3.10. Animas Corporation (Johnson & Johnson)
9.3.11. Beta Bionics, Inc.
9.3.12. Valeritas Holdings, Inc.
9.3.13. Debiotech SA
9.3.14. Senseonics Holdings, Inc.
9.3.15. Sanofi
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
List of Tables
TABLE 1. Global Continuous Subcutaneous Insulin Infusion Market, Report Scope
TABLE 2. Global Continuous Subcutaneous Insulin Infusion Market Estimates & Forecasts by Region 2022-2032 (USD Million/Billion)
TABLE 3. Global Continuous Subcutaneous Insulin Infusion Market Estimates & Forecasts by Product 2022-2032 (USD Million/Billion)
TABLE 4. Global Continuous Subcutaneous Insulin Infusion Market Estimates & Forecasts by Patient Type 2022-2032 (USD Million/Billion)
TABLE 5. Global Continuous Subcutaneous Insulin Infusion Market Estimates & Forecasts by End-Use 2022-2032 (USD Million/Billion)
TABLE 6. Global Continuous Subcutaneous Insulin Infusion Market by Segment, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 7. Global Continuous Subcutaneous Insulin Infusion Market by Region, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 8. Global Continuous Subcutaneous Insulin Infusion Market by Segment, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 9. Global Continuous Subcutaneous Insulin Infusion Market by Region, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 10. Global Continuous Subcutaneous Insulin Infusion Market by Segment, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 11. Global Continuous Subcutaneous Insulin Infusion Market by Region, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 12. Global Continuous Subcutaneous Insulin Infusion Market by Segment, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 13. Global Continuous Subcutaneous Insulin Infusion Market by Region, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 14. Global Continuous Subcutaneous Insulin Infusion Market by Segment, Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 15. U.S. Continuous Subcutaneous Insulin Infusion Market Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 16. U.S. Continuous Subcutaneous Insulin Infusion Market Estimates & Forecasts by Product 2022-2032 (USD Million/Billion)
TABLE 17. U.S. Continuous Subcutaneous Insulin Infusion Market Estimates & Forecasts by Product 2022-2032 (USD Million/Billion)
TABLE 18. Canada Continuous Subcutaneous Insulin Infusion Market Estimates & Forecasts, 2022-2032 (USD Million/Billion)
TABLE 19. Canada Continuous Subcutaneous Insulin Infusion Market Estimates & Forecasts by Product 2022-2032 (USD Million/Billion)
TABLE 20. Canada Continuous Subcutaneous Insulin Infusion Market Estimates & Forecasts by Product 2022-2032 (USD Million/Billion)
This list is not complete, final report does contain more than 100 tables. The list may be updated in the final deliverable.
List of Figures
FIG 1. Global Continuous Subcutaneous Insulin Infusion Market, Research Methodology
FIG 2. Global Continuous Subcutaneous Insulin Infusion Market, Market Estimation Techniques
FIG 3. Global Market Size Estimates & Forecast Methods
FIG 4. Global Continuous Subcutaneous Insulin Infusion Market, Key Trends 2023
FIG 5. Global Continuous Subcutaneous Insulin Infusion Market, Growth Prospects 2022-2032
FIG 6. Global Continuous Subcutaneous Insulin Infusion Market, Porter’s 5 Force Model
FIG 7. Global Continuous Subcutaneous Insulin Infusion Market, PESTEL Analysis
FIG 8. Global Continuous Subcutaneous Insulin Infusion Market, Value Chain Analysis
FIG 9. Global Continuous Subcutaneous Insulin Infusion Market by Segment, 2022 & 2032 (USD Million/Billion)
FIG 10. Global Continuous Subcutaneous Insulin Infusion Market by Segment, 2022 & 2032 (USD Million/Billion)
FIG 11. Global Continuous Subcutaneous Insulin Infusion Market by Segment, 2022 & 2032 (USD Million/Billion)
FIG 12. Global Continuous Subcutaneous Insulin Infusion Market by Segment, 2022 & 2032 (USD Million/Billion)
FIG 13. Global Continuous Subcutaneous Insulin Infusion Market by Segment, 2022 & 2032 (USD Million/Billion)
FIG 14. Global Continuous Subcutaneous Insulin Infusion Market, Regional Snapshot 2022 & 2032
FIG 15. North America Continuous Subcutaneous Insulin Infusion Market 2022 & 2032 (USD Million/Billion)
FIG 16. Europe Continuous Subcutaneous Insulin Infusion Market 2022 & 2032 (USD Million/Billion)
FIG 17. Asia Pacific Continuous Subcutaneous Insulin Infusion Market 2022 & 2032 (USD Million/Billion)
FIG 18. Latin America Continuous Subcutaneous Insulin Infusion Market 2022 & 2032 (USD Million/Billion)
FIG 19. Middle East & Africa Continuous Subcutaneous Insulin Infusion Market 2022 & 2032 (USD Million/Billion)
FIG 20. Global Continuous Subcutaneous Insulin Infusion Market, Company Market Share Analysis (2023)
This list is not complete, final report does contain more than 50 figures. The list may be updated in the final deliverable.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us